ALNYLAM PHARMACEUTICALS, INC. Quarterly Return On Assets in % from Q1 2011 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Alnylam Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2011 to Q2 2024.
  • Alnylam Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -1.88 %, a 93.9% increase year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Return On Assets for 2023 was -12.2 %, a 62.7% increase from 2022.
  • Alnylam Pharmaceuticals, Inc. annual Return On Assets for 2022 was -32.7 %, a 33% decline from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Return On Assets for 2021 was -24.6 %, a 11.5% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -1.88 +28.8 +93.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -8.92 +21.9 +71.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -12.2 +20.5 +62.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -14.4 +19.5 +57.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -30.7 -2.39 -8.46% Apr 1, 2023 Jun 30, 2023
Q1 2023 -30.9 -5.45 -21.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -32.7 -8.1 -33% Oct 1, 2022 Dec 31, 2022
Q3 2022 -33.9 -9.35 -38.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -28.3 -1.95 -7.41% Apr 1, 2022 Jun 30, 2022
Q1 2022 -25.4 +0.87 +3.31% Jan 1, 2022 Mar 31, 2022
Q4 2021 -24.6 +3.18 +11.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -24.6 +6.82 +21.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -26.3 +5.65 +17.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -26.3 +9.43 +26.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -27.8 +8.91 +24.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -31.4 +5.76 +15.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -32 +11.1 +25.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -35.7 +9.79 +21.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -36.7 +7.08 +16.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -37.1 +0.37 +0.99% Jul 1, 2019 Sep 30, 2019
Q2 2019 -43 -10.7 -33.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 -45.5 -14.2 -45.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -43.8 -10.6 -31.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -37.5 -1.93 -5.42% Jul 1, 2018 Sep 30, 2018
Q2 2018 -32.3 +2.16 +6.27% Apr 1, 2018 Jun 30, 2018
Q1 2018 -31.3 +1.27 +3.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -33.2 -2.06 -6.62% Oct 1, 2017 Dec 31, 2017
Q3 2017 -35.6 -6.84 -23.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -34.4 -8.3 -31.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -32.6 -8.41 -34.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -31.1 -11.7 -60.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -28.7 -13.2 -84.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -26.1 -11.7 -81.6% Apr 1, 2016 Jun 30, 2016
Q1 2016 -24.1 -10.6 -78.1% Jan 1, 2016 Mar 31, 2016
Q4 2015 -19.4 +15.1 +43.8% Oct 1, 2015 Dec 31, 2015
Q3 2015 -15.6 +26.6 +63.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -14.4 +33.5 +70% Apr 1, 2015 Jun 30, 2015
Q1 2015 -13.6 +41.4 +75.3% Jan 1, 2015 Mar 31, 2015
Q4 2014 -34.5 -14.7 -74.2% Oct 1, 2014 Dec 31, 2014
Q3 2014 -42.2 -13.7 -47.9% Jul 1, 2014 Sep 30, 2014
Q2 2014 -47.9 -19.7 -69.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -54.9 -25.3 -85.5% Jan 1, 2014 Mar 31, 2014
Q4 2013 -19.8 +13.6 +40.7% Oct 1, 2013 Dec 31, 2013
Q3 2013 -28.5 -10.1 -55% Jul 1, 2013 Sep 30, 2013
Q2 2013 -28.2 -11.6 -70.1% Apr 1, 2013 Jun 30, 2013
Q1 2013 -29.6 -13.1 -78.8% Jan 1, 2013 Mar 31, 2013
Q4 2012 -33.4 -15.7 -88.8% Oct 1, 2012 Dec 31, 2012
Q3 2012 -18.4 -4.18 -29.4% Jul 1, 2012 Sep 30, 2012
Q2 2012 -16.6 -4.27 -34.7% Apr 1, 2012 Jun 30, 2012
Q1 2012 -16.6 -4.81 -40.9% Jan 1, 2012 Mar 31, 2012
Q4 2011 -17.7 Oct 1, 2011 Dec 31, 2011
Q3 2011 -14.2 Jul 1, 2011 Sep 30, 2011
Q2 2011 -12.3 Apr 1, 2011 Jun 30, 2011
Q1 2011 -11.8 Jan 1, 2011 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.